학술논문
KEYNOTE-495/KEYIMPACT: INTERIM ANALYSIS OF A RANDOMIZED, BIOMARKER-DIRECTED, PHASE 2 TRIAL OF PEMBROLIZUMAB-BASED COMBINATION THERAPY FOR NON-SMALL CELL LUNG CANCER (NSCLC)
Document Type
Journal
Author
Gutierrez, Martin; Lam, Wei-Sen; Hellmann, Matthew; Gubens, Matthew; Aggarwal, Charu; Tan, Daniel Shao Weng; Felip, Enriqueta; Chiu, Joanne W. Y.; Lee, Jong-Seok; Yang, James Chih-Hsin; Garon, Edward; Finocchiaro, Giovanna; Ahn, Myung-Ju; Luft, Alexander; Landers, Gregory; Basso, Andrea; Ma, Hua; Kobie, Julie; Palcza, John; Cristescu, Razvan; Fong, Lawrence; Snyder, Alexandra; Yuan, Jianda; Herbst, Roy
Source
Subject
Language
English
ISSN
20511426